Research Catalog

Perspectives on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining perspectives on the 340B Drug Discount Program, March 15, 2018.

Title
Perspectives on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining perspectives on the 340B Drug Discount Program, March 15, 2018.
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author.
Publication
Washington : U.S. Government Publishing Office, 2020.

Details

Description
iii, 70 pages; 24 cm.
Series Statement
  • S. hrg. ; 115-810
  • United States. Congress. Senate. S. hrg. ; 115-810.
Subject
  • 340B Drug Pricing Program (U.S.)
  • Prescription pricing > Government policy > United States
  • Drugs > Prices > Government policy > United States
  • Poor > Pharmaceutical assistance > United States
  • Older people > Pharmaceutical assistance > United States
  • Drugs > Prices > Government policy
  • Older people > Pharmaceutical assistance
  • Poor > Pharmaceutical assistance
  • Prescription pricing > Government policy
  • United States
Genre/Form
Legislative hearings.
Note
  • Shipping list no.: 2021-0014-M.
Bibliography (note)
  • Includes bibliographical references.
Event (note)
  • Date of hearing: 2018-03-15.
Reproduction (note)
  • Microfiche.
Call Number
GPO Microfiche Y 4.L 11/4:S.HRG.115-810
LCCN
29-412
OCLC
marcive1284808846
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author.
Title
Perspectives on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining perspectives on the 340B Drug Discount Program, March 15, 2018.
Publisher
Washington : U.S. Government Publishing Office, 2020.
Type of Content
text
Type of Medium
microform
Type of Carrier
microfiche
Series
S. hrg. ; 115-810
United States. Congress. Senate. S. hrg. ; 115-810.
Reproduction
Microfiche. [Washington, D.C.] : U.S. Government Publishing Office, [2020?] 1 microfiche : negative.
Bibliography
Includes bibliographical references.
Performer
Hearing witnesses: Siegel, Bruce, MD, MPH, President and CEO America's Essential Hospitals; Reilly, Lori M., Executive Vice President, Policy, Research, and Membership, Pharmaceutical Research and Manufacturers of America, Washington, DC; Veer, Sue, MBA, President and Chief Executive Officer, Carolina Health Centers, Inc., Greenwood, SC; Hill, Joseph, M. III, MA, Director, Government Relations Division, American Society of Health-System Pharmacists, Bethesda, MD.
Event
Date of hearing: 2018-03-15.
Other Form:
Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Perspectives on the 340B Drug Pricing Program (OCoLC)1182634779
Online version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Perspectives on the 340B Drug Pricing Program (OCoLC)1156626967
Other Standard Identifier
29-412 (GPO jacket number)
Gpo Item No.
1043-B (MF)
Sudoc No.
Y 4.L 11/4:S.HRG.115-810
View in Legacy Catalog